Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maier-Salamon

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 19, 2006
Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1M Miksits, A Maier-Salamon, S Aust, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill PatientsM G Vossen, D Knafl, M Haidinger, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Doripenem Treatment during Continuous Renal Replacement TherapyM G Vossen, J M Wenisch, A Maier-Salamon, et al.
Clinical Pharmacology and Therapeutics|March 5, 2016
Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood-Brain BarrierM Bauer, K Römermann, R Karch, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement TherapyM G Vossen, L Ehmann, S Pferschy, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 19, 2006
Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1M Miksits, A Maier-Salamon, S Aust, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill PatientsM G Vossen, D Knafl, M Haidinger, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Doripenem Treatment during Continuous Renal Replacement TherapyM G Vossen, J M Wenisch, A Maier-Salamon, et al.
Clinical Pharmacology and Therapeutics|March 5, 2016
Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood-Brain BarrierM Bauer, K Römermann, R Karch, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement TherapyM G Vossen, L Ehmann, S Pferschy, et al.
Pageof 1